in

Gilead CEO expects remdesivir to effectively treat Covid strains found in UK, South Africa

“I expect remdesivir with these variants will continue to make an impact on patients,” Gilead Sciences CEO Daniel O’Day told CNBC.

Source: Business - cnbc.com

BioNTech says Covid vaccine is effective against key new strains; to publish more data in days

It Could Be a Great Year, if Your Business Survives Winter